Abstract
Significance: Na v 1.1 is a potential therapeutic target for brain disorders, such as epilepsy, Alzheimer's disease, and autism. Moreover, this voltage-gated sodium (Na v ) channel subtype contributes to mechanical pain by regulating excitability in a specific subset of sensory neurons within the peripheral nervous system. The results of our study shed light on the molecular mechanisms underlying Na v 1.1 inactivation and suggest pharmacologic approaches to address relevant disease-related phenotypes.
Funding Information
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) (F32NS081907)
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) (R37NS065071)
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) (R01NS081115)
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) (R01NS091352)
  • NIGMS (R01GM109762)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) (K08HL116790)

This publication has 41 references indexed in Scilit: